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Abstract
Local delivery of neurotrophic factors is a pillar of neural repair strategies in the periph‐
eral nervous system. The main disadvantage of the free growth factors is their short 
half‐life of few minutes. In previous studies, it was demonstrated that conjugation of 
various neurotrophic factors to iron oxide nanoparticles (IONP) led to stabilization of 
the growth factors and to the extension of their biological activity compared to the free 
factors. In vitro studies performed on organotypic dorsal root ganglion (DRG) cultures 
seeded in NVR gel (composed mainly of hyaluronic acid and laminin) revealed that the 
glial cell–derived neurotrophic factor (GDNF) conjugated to IONP‐enhanced early nerve 
fiber sprouting and accelerated the onset and progression of myelin significantly earlier 
than the free GDNF and other free and conjugated factors. The present article summa‐
rizes results of in vivo study, aimed to test the effect of free versus conjugated GDNF 
on regeneration of the rat sciatic nerve after a severe segment loss. We confirmed that 
nerve device enriched with a matrix with GDNF gives more successful results in term of 
regeneration and functional recovery in respect to the hollow tube; moreover, there are 
no detectable differences between free versus conjugated GDNF.
Keywords: GDNF conjugated iron oxide nanoparticles, chitosan tube, peripheral nerve 
regeneration
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Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
The incidence of nerve injury is quite high in the world, related also to the exposition of nerve 
tissue in the body. Despite the good regeneration ability retained by peripheral nerve sys‐
tem in adulthood, nerve injuries are associated with high morbidity and deep alteration of 
patient’s life [1]. Severe transection injuries, in which nerve continuity is lost, require a surgical 
approach, specially where the distance between the proximal and the distal nerve stumps is 
extended. In order to avoid negative side effect of the autologous nerve graft, the current gold 
standard technique, and to improve the functional recovery and reduce neuropathic pain, 
various biosynthetic nerve grafts have been developed to bridge the two nerve stumps [2–4]. 
Some of the artificial nerve guides have been approved for clinical use, and indeed, their use 
in reconstructive surgery is restricted because they still show limitations, principally for long‐
distance repair [5]. One category of these nerve conduits is defined absorbable conduit, accord‐
ing to their characteristic to be degraded in the host body; among these, the chitosan tube has 
been widely used in pre‐clinical studies obtaining promising results [4, 6, 7]. Chitosan is a 
polysaccharide derived from chitin, it is biocompatible, and it can promote glial cells survival 
and neurite outgrowth [8–10]. It has been shown that hollow chitosan tube can be effective as 
autologous nerve graft for bringing 10‐mm gap in rat sciatic nerve model [7, 11, 12]. In order 
to increase the performance of chitosan tube for long defect repair; here, we filled the tube 
with a hydrogel, called NVR gel, composed mainly by hyaluronic acid and laminin. Previous 
works demonstrated that NVR gel is a promising hydrogel that allow neurite outgrowth and 
cell survival in vitro [13]. Furthermore, we used NVR gel as a carrier for neurotrophic factors. 
In particular, we focus our attention on glial cell line–derived neurotrophic factor (GDNF), 
which is mainly involved in motor neuron regrowth and remyelination [14–16]. After nerve 
injury, endogenous growth factors are released by neuronal and glial cells from the distal 
nerve stump, and they can stimulate and guide axon regeneration; yet, this support is inef‐
fective in regeneration over long distance and extended in time due to the short life of neuro‐
trophic factors and the decline of their production [17, 18]. The implementation of the nerve 
conduit with neurotrophic factors has the aim to maintain elevated the concentration of these 
growth factors and to extend their action for the prolonged time needed for axons to reach the 
target. For this purpose, we use the NVR gel as a scaffold for the release of GDNF conjugated 
to iron oxide nanoparticles (GDNF‐IONP). We have previously demonstrated that conjugation 
of various neurotrophic factors to iron oxide nanoparticles (IONP) led to stabilization of the 
growth factors and to prolonged biological activity respect to the non‐conjugated factors [19]. 
IONP are considered biocompatible and biodegradable, they are actually used for various bio‐
medical application [20–22], and thus, they were suggested for in vivo use for peripheral nerve 
regeneration [23]. Moreover, in vitro experiments showed that the combination of NVR gel 
and IONP represents a permissive environment to neurite outgrowth [19], and GDNF‐IONP 
has been shown to accelerate the onset and progression of myelin in organotypic dorsal root 
ganglion (DRG) cultures seeded in NVR gel, significantly earlier than the free GDNF and other 
free and conjugated factors [24].
In the present study, we explored the efficacy of chitosan tube enriched with NVR gel and 
GDNF‐IONP to the repair of critical length, 15 mm, sciatic nerve defect in rat model. We 
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evaluated the functional and morphological outcome of nerve regeneration at 5 months after 
nerve injury, analyzing the effects given by the presence of NVR gel alone, NVR gel with 
GDNF‐IONP or free GDNF inside the chitosan tube respect to the empty nerve device.
2. Materials and methods
2.1. Synthesis of GDNF‐IONP
Dextran‐coated iron oxide magnetic nanoparticles of 10 nm diameter were prepared as 
described previously [3]. The dextran coating was used to covalently bind the protein GDNF 
using divinyl sulfone binding reagent [1].
2.2. NVR gel preparation
NVR gel is a matrix supporting cell growth and survival composed by high‐molecular‐
weight hyaluronic acid (3 × 106 Da, BTG Polymers, Kiryat Malachi, Israel) and laminin (Sigma, 
Rehovot, Israel) [4]. For the in vivo application as a tube filler, the NVR gel was diluted in 
nutrient medium corresponding to Dulbecco’s modified eagle medium‐nutrient mixture F‐12 
(DMEM‐F12), supplemented with 10% fetal calf serum (FCS), 2‐nM glutamine, 6‐g/L d‐glu‐
cose, 25‐μg/mL gentamycine and 50‐ng/mL IGF‐I. The final concentration of the solution is 
0.5% to render more suitable gel manipulation. NVR gel was filled into the chitosan tubes 
during the surgical implantation using a syringe.
2.3. Preparation of chitosan conduit
Chitosan tubes were manufactured by Medovent GmbH (Mainz, Germany) under ISO 13485 
conditions from chitin tubes made following three main procedures: the extrusion process, 
distinctive washing, and hydrolysis steps to reach the required medium degree of acetylation 
(DAII). Tubes were finally cut into the length of 17 mm and treated with ethylene oxide for 
sterilization.
2.4. Animals
All animal experiments were approved by the Institutional Animal Care and Usage Committee 
(IACUC) and adhered strictly to the Animal Care guidelines. Female Wistar rats were brought 
to the vivarium 2 weeks prior to the surgery and housed two per cage with a 12‐h light/dark 
cycle, with free access to food and water.
2.5. Experiment design and surgical technique
Fifty female Wistar rats, weighing 200–250 g each, were studied using an experimental model 
for producing a complete peripheral nerve injury with massive nerve defect that has recently 
been described [7]. During the 2 weeks before surgery and for the entire study, the rats were 
given Amitriptyline in their drinking water, in order to decrease autotomy—self‐eating of 
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toes—in the operated limb. Before surgery, a general anesthesia was induced with intraperi‐
toneal injection of xylazine (15 mg/kg) and ketamine (50 mg/kg).
During the surgical procedures, a high magnification microscope was used. The left sciatic 
nerve was uncovered and disconnected from biceps femoris and semimembranous muscles, 
beginning from the area of branches to the glutei and hamstring muscles and distally to 
the trifurcation into peroneal, tibial, and sural nerves. At the third femur level, the sciatic 
nerve was fully transected using microsurgical scissors, and a 15‐mm nerve segment was 
removed.
Afterward, the rats were divided into five experimental groups according to the type of 
implant: empty tubes (n = 10); tubes filled with NVR gel (n = 10); tubes filled with NVR gel 
enriched with free GDNF (n = 10); tubes filled with NVR gel enriched with GDNF‐IONP 
(n = 10); and autologous nerve grafts (n = 10).
For nerve reconstruction in treatment groups, a 17‐mm chitosan empty tube was located 
between the proximal and the distal sides of the transected sciatic nerve. Both proximal and 
distal sides of the sciatic nerve were positioned 1 mm into the tube ends, providing a 15‐mm 
nerve gap between the proximal and distal ends. Then, the tube ends were sutured to the epi‐
neurium at the proximal and distal nerve stumps using a 9‐0 nonabsorbable suture.
In control group (autologous nerve graft reconstruction), after exposition the left sciatic nerve, 
a 15‐mm nerve segment was severely cut, using micro scissors, at the femur level, below the 
superior gluteal nerve and above the dissection of the sciatic nerve into the tibial and peroneal 
nerves. Immediately thereafter, inverse end‐to‐end coaptation of the nerve segment was per‐
formed using 2–3 nonabsorbable 10‐0 sutures. Coaptation of nerve fascicles was performed 
to preserve all the fascicles within the epineural sac. Then, the muscular, subcutaneous, and 
skin layers were closed.
2.6. End‐point assessments
Assessments before and after surgery (30, 90, and 150 days postoperatively) were carried out 
in a blinded manner without disclosure of rat’s affiliation to the evaluating team. The assess‐
ments consisted of functional motor assessment of the sciatic nerve utilizing sciatic function 
index (SFI), somatosensory evoked potentials (SSEP), ultrasound evaluation, and morpho‐
logical analysis.
2.6.1. Electrophysiological evaluation
SSEPs were recorded in both the operated and intact limbs using a Dantec™ KEYPONT® 
PORTABLE. Conductivity of the sciatic nerve was measured by stimulating the sciatic nerve 
at the level of the tarsal joint with simultaneous recording from the skull over the somatosen‐
sory cortex in anesthetized rats. Two subcutaneous needle electrodes were placed under the 
skin of the skull, when the active electrode was placed above the somatosensory cortex along 
the midline, and the reference electrode was placed between the eyes. The ground electrode 
was placed subcutaneously on the dorsal neck. Stimulation of the sciatic nerve was conducted 
by a set of two polarized electrodes located on the lateral aspect of the tarsal joint. The sciatic 
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nerve was stimulated by 300 pulses of 0.2 ms in duration with a rate of 3 Hz. The intensity of 
the stimulus was set to 2–5 mA, causing a slight twitching of the limb under observation. A 
response to the stimulus was considered positive if an evoked potential appeared in at least 
two consecutive tests.
2.6.2. Ultrasound evaluation (US)
During the observational period, imaging studies employing ultrasonography were carried 
out, in anesthetized rats, for real‐time evaluation of nerve regeneration inside the chitosan 
tubes. The lateral aspect of the right leg was shaved to improve transducer contact. The sono‐
graphic scanning technique included longitudinal and transverse sections. US examinations 
were performed using conventional US units equipped with color Doppler capabilities using 
7–15 MHz linear transducer, yielding an axial resolution of 0.2–0.4 mm. The identification of 
the chitosan conduit on the US image was based on the recognition of a hyperechoic structure 
of a tubular shape in the longitudinal axis and a circular shape on the transverse section.
2.6.3. Sample resin embedding
All the nerve samples were harvested 5 months after the surgical implantation. The complete 
tube was collected taking care to preserve part of the proximal and the distal nerve and was 
fixed for 4–6 h at 4°C in 0.1‐M phosphate buffer (pH 7.4) with 2.5% glutaraldehyde. After the 
fixation, all the tubes were opened using a scalpel and removed in order to free and clean 
the regenerated nerve inside the tube and prepared it to be processed for resin inclusion. 
The post‐fixation of nerves regenerated inside tubes was done using 2% osmium tetroxide 
for 2 h, and then, the samples were dehydrated in ethanol from 30 to 100%. Two washings of 
7 m using propylene oxide were performed, and then, samples were embedded in a mixture 
of propylene oxide and Glauerts’ mixture of resins (50% Araldite HY964, 50% Araldite M 
and 0.5% dibutylphthalate) mixed in equal parts and left 1 h at room temperature. A sec‐
ond embedding with Glauerts’ mixture of resins alone for an overnight was performed. The 
Glauerts’ mixture of resins was changed, and samples were left 37°C for 1 h. Two following 
samples embedding were done using resin with 2% of accelerator 964. Samples were left for 
3 days at 60°C.
For stereological analysis, resin‐embedded nerve was cut from the distal stump using Ultracut 
UCT ultramicrotome (Leica Microsystems, Wetzlar, Germany) to obtain transverse semi‐thin 
sections (2.5 μm of thickness) for optical analysis.
2.6.4. Morphometrical analysis
Semi‐thin transverse nerve sections were stained with 1% toluidine blue and analyzed in 
high‐resolution light microscopy. The qualitative and quantitative morphological analysis 
was performed with DM4000B microscope and DFC320 digital camera, using IM50 image 
manager system (Leica Microsystems). One randomly selected semi‐thin section was used 
to measure the total cross‐section area of the nerve. Using a systematic protocol described 
in [25], 12–16 fields were selected, and the following parameters were measured: mean fiber 
density (number of fiber/field area), total number of myelinated fibers (mean fiber density × 
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area of the nerve section) fiber area, axon area, fiber diameter (D) and fiber axon (d), myelin 
thickness [(D − d)/2], and g‐ratio (d/D).
2.7. Statistical analysis
Functional and electrophysiological analysis and calculations were done using MatLab soft‐
ware (Ver. 2008b, The MathWorks, Inc.). Nonparametric statistics were used in this study. 
Hence, all figures are presented with median ± mad. Significance levels were calculated using 
a Mann‐Whitney U test and a Wilcoxon signed rank test. SSEP responses were analyzed as 
categorical parameters using χ2 test.
For the stereological analysis, more than five sciatic nerves were analyzed for each single 
groups (autograft, n = 5; tube with NVR gel, n = 8; tube with NVR gel enriched with GDNF‐
IONP, n = 8; tube with NVR gel enriched with free GDNF, n = 7). The ANOVA one way 
followed by Bonferroni post hoc test was performed using SPSS Statistic Program. Results 
are reported as mean +SD.
3. Results
All the five defined animal groups (autograft, DAII empty tube, DAII tube with NVR gel, 
DAII tube with NVR gel and GDNF‐IONP, DAII tube with NVR gel with GDNF) were fol‐
lowed‐up until 5 months after nerve injury. During the follow‐up period, the regeneration 
and the position of the implanted tubes were evaluated using ultrasound observation that 
enabled to observe in vivo the condition of the tube without scarifying the rats. All implants 
were found to be complete and in correct position (Figure 1).
Five months after nerve guide implantation, animals were sacrificed, and all the chitosan 
tubes were removed for nerve regeneration evaluation. For morphological and morphometri‐
cal analysis, the autograft group was considered as the control group, since in the comparison 
with healthy nerve already revealed the best regenerative aspect [26, 27].
A nerve regeneration was observed in all of the investigated conditions: a higher percentage 
of regenerated nerves was detected for tubes containing NVR gel with GDNF‐IONP (100%), 
while a lower percentage of regenerated nerves (56%) was observed for tubes containing NVR 
Figure 1. Ultrasound evaluation of implanted chitosan tube. (A) 20‐day post‐tube implantation—no regeneration is 
visible inside the tube and (B) 90 days post‐tube implantation—nerve filaments are present inside the tube reconnecting 
nerve stumps (white arrows).
Peripheral Nerve Regeneration - From Surgery to New Therapeutic Approaches Including Biomaterials and Cell-Based
Therapies Development
202
gel with GDNF; the lowest percentage of regenerated nerves was found for empty tubes (11%) 
or tubes filled with NVR gel alone (30%).
3.1. Functional analysis
In order to assess the functional recovery, we used the electrophysiological evaluation. We 
recorded SSEP at different time points (0, 30, 90 and 150 days after injury) calculating SSEP 
peak to peak (P2P) amplitude (NR type) in which the operated limb was compared to the 
intact limb (Figure 2). Regarding the operated limb, all groups showed a decrease at the first 
follow‐up (30 days), followed by an increase, except for the tube filled with NVR gel and NVR 
gel enriched with GDNF‐IONP, which recovered only after 90 days. Interestingly, for what 
concerns the intact limb, the animal group treated with tube filled with NVR gel enriched 
with GDNF‐IONP also exhibited a decrease in amplitude following the operation and then 
recovered, while both the autologous nerve graft reconstruction and the tube filled with NVR 
gel enriched with free GDNF groups demonstrated an increase in P2P.
It was interesting to observe the comparison of the P2P among the different treatments in both 
the operated and intact limbs (Figure 3). At 30 days after injury, P2P amplitude is significantly 
higher in the group of animals in which truncated nerves were repaired with tubes filled with 
NVR gel and GDNF‐IONP respect to those repaired with autologous nerve graft (p < 0.05).
Figure 2. Comparison of somatosensory evoked potentials (SSEP) peak‐to‐peak (P2P) amplitude among various treatments. 
Data were gathered from each limb separately (operated and intact) at four follow‐up periods: 0 (pre‐operatively), 30, 90, 
and 150 days. Values are presented as median ± mad. Statistical analysis: Wilcoxon signed rank test. *p < 0.05.
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The same treatment seemed to provoke significant decrease in P2P amplitude at the intact limb 
but only during the first time point investigated. The difference was observed in relation to 
the empty tube group (p < 0.05), and the tube filled with NVR gel enriched with free GDNF 
(p < 0.05).
In order to normalize the results, we decided to subtract P2P measurement in the operated 
limb with the P2P measurement in the intact limb (Figure 4) in each of the four follow‐up 
time points (0, 30, 90, and 150 days). The “0” value indicates similar amplitude in both intact 
and operated limbs. Since a dramatic decrease in amplitude is an indicator of neurological 
dysfunction, we assume that a large shift down from “0” is a marker for this pathology. As 
expected, at time point 0 (pre‐operation), all groups exhibited an amplitude difference very 
close to “0.” During the follow‐up, most treatments exhibited a decrease at the amplitude. 
The most robust and sustained decrease was found at the empty tube group. Surprisingly, 
the rat group that was treated with tube filled with NVR gel enriched with GDNF‐IONP had 
no decrease.
3.2. Morphological and morphometrical analysis
To determine how structural aspect of regenerated nerves is influenced by the choice of the 
dispositive used to repair the long gap, we performed morphological and morphometrical 
analysis on nerve regenerated inside the chitosan tube 5 months after the surgery. Beside 
only two animals showed regeneration in empty tube group, this group was excluded from 
morphometrical analysis. The morphometric quantification was carried out in the distal part 
of the regenerated nerve inside the tube (Figure 5A). Semi‐thin section of regenerate nerves 
was used for the analysis and compared to the distal part of regenerated nerves of autograft 
group, our positive control (Figure 5B–E).
Figure 3. Comparison among the various treatments. Data were gathered from each limb separately (operated and 
intact) at four follow‐up periods: 0 (pre‐operatively), 30, 90, and 150 days. Values are presented as median ± mad 
statistical analysis: Mann‐Whitney rank‐sum test. *p < 0.05.
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It is possible to notice the similarity among experimental groups in which nerve cross sections 
are organized in fascicles with small fibers.
The number of myelinated fibers is significantly higher in autograft group (p ≤ 0.001) that 
remains the gold standard of regeneration (Figure 6); nevertheless, it is important to notice 
that in the experimental group repaired with the tube enriched with NVR gel and GDNF‐
IONP, the number of myelinated fibers is statistically significant higher (p ≤ 0.05) respect to 
the group repaired with the conduit functionalized with NVR gel alone (Figure 6).
The myelin thickness parameter, recorded for the group repaired using a tube with NVR 
gel alone, shows a statistically relevant reduction compared to autograft group (p ≤ 0.05). As 
regard the other parameters considered, it is interesting to note that there are no differences 
among the experimental groups.
Figure 4. P2P measurement normalized to the intact limb. The graph shows the data obtained through the subtraction 
of P2P measurement in the operated limb with P2P measurement in the intact limb. The “0” value indicates similarity 
between the two limbs. Values are presented as median ± mad.
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Figure 5. Morphological analysis of regenerated nerves inside chitosan tube. (A) Representative photos of sciatic rat 
regenerated nerves harvested inside chitosan tube 5 months after the implantation. (B–E) The figure shows representative 
semi‐thin transversal nerve sections of regenerated sciatic nerves used for morphometrical analysis. For autograft group 
(B), the distal nerve is represented; for tube with NVR gel alone (C), tube with NVR gel enriched with GDNF‐IONP (D) 
and tube with NVR gel enriched with free GDNF (E); the pictures refer to the nerve found inside the chitosan tube. For 
all the groups, a good regeneration is visible.
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4. Discussion
A wide range of conduits with different internal design have been tested for reconstruction of 
peripheral nerves in animal models [28]. The efforts concern the attempt to replace the current 
gold standard, the autologous nerve graft, above all in the case of very serious injury and to 
avoid negative side‐effects [2, 4]. Chitosan conduits, among the absorbable forms, have been 
shown to be able of supporting the peripheral nerve regeneration with values of recovery 
Figure 6. Morphometrical analysis of regenerated nerve inside the chitosan tube. The analysis was performed on semi‐
thin transverse sections of the regenerated nerves 5 months after implantation. For autograft group (used as control), 
the distal part of the nerve was analyzed; for all the other groups, the values in the graphs are referred to the distal 
regenerated nerve found inside the chitosan tube. The graphs show the total number of number of myelinated fibers, 
the axon diameter, the fiber diameter, the myelin thickness, and the g‐ratio. In the filled tubes, there is less myelinated 
fibers respect to the autograft, but all the other parameters are comparable with the autograft. The two groups with 
GDNF factors, free or conjugated to iron‐oxide nanoparticles, are similar. All data are presented as mean + SD. Statistical 
analysis: One‐way ANOVA with post hoc Bonferroni Test. *p < 0.05; **p < 0.01; ***p < 0.001.
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fully comparable to the surgical gold standard technique, with regard to sciatic nerve lesions 
of 10 mm in the rat animal model [7, 11]. Despite this, in case of nerve injuries with a con‐
siderable loss of substance, it is necessary to functionalize the conduit, to provide a filler, in 
order to prevent the collapse of the walls, and to provide a releasing system of neurotrophic 
molecules able to accelerate the regenerative processes [26]. In this study, we used the NVR 
gel, made of hyaluronic acid and laminin [13], as internal filler and for the release of the neu‐
rotrophic factor GDNF, which has been further enhanced by stabilizing its duration through 
a covalent conjugation with IONP [19].
We have previously demonstrated that the administration of this factor induces an early 
myelination in organotypic cultures of neonatal DRG [24]. The whole device has been pro‐
posed for the repair of a rat sciatic nerve lesion with severe loss of substance (15 mm). In this 
study, the nerve regeneration and the correct position of the device have been constantly 
monitored. Ultrasound observations and functional analysis have allowed us to carry out 
regular follow‐up (30, 90, and 150 days after surgery).
The ultrasound analysis carried out on the implants revealed that none of these have under‐
gone a shift from the correct position by the moment of the surgery. The two representative 
figures show the implanted tube at 20 and 90 days after surgery; at the experimental time 
90 days, nerve regeneration appears through nerve fascicles.
Electrophysiological analysis on the five experimental groups demonstrates a nerve conduc‐
tivity recovery (P2P amplitude) by the end of the follow‐up period (150 days), when the tube 
enriched either with NVR gel or NVR gel and GDNF‐IONP treatments displayed a complete 
recovery, as time 0, whether other treatments showed only a partial recovery. Normalizing 
the SSEP results of the operated limb (left) to the intact one (right), all groups showed a 
decrease after surgery followed by an increase, as expected, except for the group treated using 
a tube enriched with NVR gel and GDNF‐IONP that did not showed any decrease during the 
follow‐up period after surgery. These electrophysiological findings suggest that the treat‐
ment, in which a tube is enriched with NVR gel, is comparable to the autologous nerve graft 
treatment.
The morphological aspect of regenerated nerves when, after 5 months, rats were sacrificed 
and tubes explanted revealed for all the cases analyzed a good nerve regeneration.
The morphometric quantification was referred on the distal part of the regenerated nerve 
inside the tube. Semi‐thin sections of nerves were used for the analysis and compared to the 
ones from the distal part of regenerated nerves of autograft group, our positive control. All 
the nerves revealed the same cross section structure: fascicles with small fibers, a typical nerve 
regeneration framework.
It was interesting to observe similar values for the measured parameters, such as axon diam‐
eter, myelin thickness, fiber diameter, and g‐ratio, demonstrating an equal good regeneration, 
because compared with the gold standard, the autograft. The only parameter in which the 
superiority of our positive control was found was the total number of the fibers, although the 
group represented by the tube enriched with NVR gel and GDNF‐IONP had a statistically 
significant greater value compared to the tubes enriched with only NVR gel.
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5. Conclusions
In this work, we investigated the efficacy, in the repair of a nerve injury with a considerable 
loss of substance, of a conduit functionalized (i) with a factor that has been demonstrated to 
accelerate nerve regeneration, (ii) with a hydrogel, which has proven to be a good substrate 
for neurite outgrowth, (iii) and with the system of the IONP, able to stabilize the signaling of 
the factors. The analysis carried out has not shown a great improvement in nerve regeneration 
in animals treated with this functionalized device compared to the other devices investigated. 
IONPs are potentially a good candidate for nerve device enrichment; however, the best way 
to administer neurotrophic factors IONP in the tube needs further investigation, as well as the 
effects of their long time exposition.
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